Kindly MD Reports Agreement Terminations & New Obligations
Ticker: NAKAW · Form: 8-K · Filed: Oct 3, 2025 · CIK: 1946573
| Field | Detail |
|---|---|
| Company | Kindly Md, Inc. (NAKAW) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $203,017,500, b, $203,000,000, $17,500, $25,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, financial-obligation, executive-changes
TL;DR
Kindly MD terminated a deal, signed a new one, and shuffled execs. Big changes ahead.
AI Summary
Kindly MD, Inc. announced on September 29, 2025, the termination of a material definitive agreement and entered into a new direct financial obligation. The company also reported on the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements.
Why It Matters
This filing indicates significant corporate changes and new financial commitments for Kindly MD, Inc., which could impact its operational and financial future.
Risk Assessment
Risk Level: medium — The filing details material definitive agreement terminations and new financial obligations, alongside executive and director changes, suggesting potential instability or strategic shifts.
Key Players & Entities
- Kindly MD, Inc. (company) — Filer of the 8-K report
- September 29, 2025 (date) — Earliest event reported date
FAQ
What was the nature of the material definitive agreement that was terminated?
The filing indicates the termination of a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What is the direct financial obligation Kindly MD, Inc. has entered into?
The filing states that Kindly MD, Inc. has entered into a direct financial obligation, but the specific terms and amount of this obligation are not detailed in the provided text.
Were there any changes in the board of directors or executive officers?
Yes, the filing reports on the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the primary business of Kindly MD, Inc. according to the filing?
Kindly MD, Inc. is classified under FINANCE SERVICES [6199] with an organization name of 09 Crypto Assets.
What is the fiscal year end for Kindly MD, Inc.?
The fiscal year end for Kindly MD, Inc. is December 31st.
Filing Stats: 1,184 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2025-10-03 17:15:27
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 NAKA The Nasdaq Stock Market LLC
- $203,017,500, b — ity in an aggregate principal amount of $203,017,500, bearing interest at a rate of 8.5% per an
- $203,000,000 — aking a cash payment to the Investor of $203,000,000, representing the outstanding principal
- $17,500 — curred by the Investor in the amount of $17,500. In connection with the repayment of th
- $25,000 — igible to receive an annual cash fee of $25,000 for his service as Committee Chair, pay
Filing Documents
- ea0260270-8k_kindly.htm (8-K) — 51KB
- ea026027001ex10-1_kindly.htm (EX-10.1) — 253KB
- ea026027001ex99-1_kindly.htm (EX-99.1) — 19KB
- 0001213900-25-096183.txt ( ) — 584KB
- naka-20250929.xsd (EX-101.SCH) — 4KB
- naka-20250929_def.xml (EX-101.DEF) — 26KB
- naka-20250929_lab.xml (EX-101.LAB) — 36KB
- naka-20250929_pre.xml (EX-101.PRE) — 25KB
- ea0260270-8k_kindly_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized. KINDLY MD, INC. Dated: October 3, 2025 By : /s/ David Bailey David Bailey Chief Executive Officer 2